Cheng Liu
Signal active
Founder, CEO
Contact Information
Social
Primary Organization
Eureka Therapeutics
Founded
2006
Employees
11-50
Industry
Biotechnology, Health Care, Medical, Therapeutics
Bio
Cheng Liu is the founder and CEO of Eureka Therapeutics, a California biotech company dedicated to antibody research and discovery for cancer immunotherapy. Prior to founding Eureka, Dr. Liu was a Principal Scientist in antibody drug discovery at Chiron (now Novartis), where he championed anti-CSF1 antibody program for treatment of bone metastasis to human clinical trials. He is the inventor of multiple issued US patents in drug discovery. In 2007, he was awarded Special US Congressional Recognition for his contributions to improving human health. Dr. Liu received his B.S. in Cell Biology and Genetics from Beijing University and a Ph.D. in Molecular Cell Biology from the University of California, Berkeley.
Location
El Sobrante, California, United States, North America
Jobs history
0
N/A
Educations
1
University of California Berkeley
Molecular Cell Biology
Profile Resume
Cheng Liu is the Founder, CEO at Eureka Therapeutics, based in United States, North America. With a background in Biotechnology, Cheng Liu has a rich history of leadership and innovation.Cheng Liu studied PhD Molecular Cell Biology at University of California Berkeley. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.